November 18, 2026 · Circulation. Arrhythmia and electrophysiology · DOI: 10.1161/CIRCEP.126.014935

Myocardial Hmgcs2-Driven Ketogenesis Promotes Atrial Fibrillation in Diabetes.

Listen to this summary

In patients and mice with type 2 diabetes, the authors asked whether elevated cardiac expression of the ketogenic enzyme Hmgcs2 contributes to atrial fibrillation (AF), independent of the liver's known role in producing circulating ketones. They found the heart becomes a major ketogenic organ in diabetes, where Hmgcs2-driven ketogenesis depletes energy reserves, increases oxidative stress and mitochondrial injury, and promotes AF and diastolic dysfunction, partly by degrading the ketolysis enzyme Oxct1 through β-hydroxybutyrylation. Cardiomyocyte-specific Hmgcs2 knockdown reduced diabetes-associated AF in mice, suggesting cardiac Hmgcs2 as a potential therapeutic target.

Lin Wang, Ruopeng Tan, Yuanjun Sun, Guiwen Xu, Qi Su, Xinyu Yang, Michael Shehata, Xiaomeng Yin, Eugenio Cingolani, Yang Liu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play